ライフサイエンスコーパス: hay fever

1 status but was lower (P < .05) with atopy or hay fever.

2 l BMI and GWG were not associated with AE or hay fever.

3 doctor-diagnosed asthma, 25.8% AE, and 4.6% hay fever.

4 es were inversely associated with asthma and hay fever.

5 ures on the incidence of asthma, eczema, and hay fever.

6 blood eosinophils from patients with ragweed hay fever.

7 arents had asthma, bronchitis, emphysema, or hay fever.

8 t atopic dermatitis, food allergy, asthma or hay fever.

9 milar for cumulative incidence of asthma and hay fever.

10 of airway infection, and chronic asthma and hay fever.

11 ated its 100th birthday for the treatment of hay fever.

12 risk of asthma and a slightly lower risk of hay fever.

13 ust microbiota with adult asthma, atopy, and hay fever.

14 The patient was an 8-year-old boy with hay fever.

15 dhood asthma, except for one SNP shared with hay fever.

16 -discovery rate, <0.05) by asthma, atopy, or hay fever.

17 rns were then related to asthma, eczema, and hay fever.

18 s pollen are the number one cause of outdoor hay fever.

19 ia were more abundant with asthma, atopy, or hay fever.

20 factors and pollen counts may play a role in hay fever.

21 nce that TRAP was associated with eczema and hay fever.

22 of climate on the US prevalence of childhood hay fever.

23 tigate associations with asthma, eczema, and hay fever.

24 for socio-demographics, comorbid asthma, and hay fever.

25 iduals without atopy, or individuals without hay fever.

26 related exposures and symptoms of asthma and hay fever.

27 (0.34; 0.23-0.51), eczema (0.43; 0.30-0.61), hay fever (0.39; 0.27-0.55), and food allergies (0.60; 0

28 2.10) for atopy, 1.04 (95%CI: 0.99-1.09) for hay fever, 0.96 (95%CI: 0.86-1.06) for any allergy.

29 (1.83; 1.58-2.13), asthma (1.31; 1.14-1.51), hay fever (1.57; 1.36-1.81), and food allergy (2.08; 1.7

30 [1.41-2.84]), AD/eczema (1.73 [1.17-2.56]), hay fever (1.93 [1.41-2.65]) and food allergies (2.69 [1

31 D/eczema (3.89 [1.34-11.32]) [corrected] and hay fever (2.46 [1.11-5.41]) were associated with even h

32 ns, including allergic asthma and rhinitis ("hay fever").(2-5) Understanding the relationships betwee

33 The summary OR for the risk of hay fever (22 studies) was 1.23, 95% confidence interval

34 gE test (29.9% vs 44.6%; P = .02) or current hay fever (3.3% vs 7.6%; P = .002).

35 for asthma, 17.1% (95% CI, 16.9%-17.3%) for hay fever, 4.2% (95% CI, 4.1%-4.3%) for food allergy, an

36 uding eczema (4.93; 1.18-20.62; P = .03) and hay fever (6.25; 1.70-22.96) but not asthma or food alle

37 a, food allergies, and seasonal allergies or hay fever, AD was associated with increased odds of diff

38 ma (adjusted HR 1.17; 95% CI, 1.06-1.29) and hay fever (adjusted HR 1.56; 95% CI, 1.22-2.01).

39 atively associated with childhood asthma and hay fever (adjusted odds ratio [OR] per category increas

40 Hay fever affects people differently and can change over

41 emisiifolia), the major cause of late summer hay fever (allergic rhinitis) in the United States and C

42 examined the causal effect of BMI on asthma, hay fever, allergic sensitization, serum total immunoglo

43 asonality depending on the country - namely 'hay fever', 'allergy' and 'pollen' - showing cultural di

44 between allergic conditions (asthma, atopy, hay fever and "any allergy") and risk of prostate cancer

45 e participants (77%) had physician-diagnosed hay fever and 65% of the participants had been tested po

46 Therapies directed against IgE can alleviate hay fever and allergic asthma.

47 Conditions such as hay fever and allergy are associated with increased risk

48 For having both hay fever and asthma by age 7 years, the association wit

49 We examined the causal effect of smoking on hay fever and asthma by using the smoking-associated sin

50 Observational studies on smoking and risk of hay fever and asthma have shown inconsistent results.

51 ngs to the most potent allergens involved in hay fever and asthma.

52 re for atopic dermatitis, the farm effect on hay fever and atopic sensitization could not be complete

53 teristics, there is a link still missing for hay fever and atopy.

54 For doctor-diagnosed hay fever and current rhinitis symptoms, the protective

55 Parental hay fever and early exposure to D pteronyssinus allergen

56 Asthma, hay fever and eczema partly coexist because they share m

57 cs play a bigger role predisposing eczema to hay fever and eczema to asthma than environmental factor

58 ecasting tools for advising individuals with hay fever and health care professionals how to prepare f

59 arental atopy history, particularly maternal hay fever and paternal asthma were related to lower Treg

60 was seen in a cluster where both parents had hay fever and pollen allergy and that of NAR, 11.0%, in

61 ial diversity was positively associated with hay fever and short-term exposure to NO(2), while it was

62 rs and pollen counts on the US prevalence of hay fever and statewide variation in prevalence.

63 he initial manifestation with progression to hay fever and then asthma, there is yet no definitive pr

64 arents had asthma, bronchitis, emphysema, or hay fever and with increased peak expiratory flow labili

65 rted medical history of asthma and/or atopy (hay fever and/or eczema/urticaria) in a historical cohor

66 sophageal reflux disease, allergic rhinitis, hay fever, and asthma, which indicates partly shared gen

67 ds were tested for associations with asthma, hay fever, and atopy in quantitative and qualitative mul

68 cultivation) was protective against asthma, hay fever, and atopy.

69 implicated in the comorbidity of asthma plus hay fever, and confirmed nine known loci.

70 ntify novel risk loci shared between asthma, hay fever, and eczema by applying a gene-based test of a

71 genetic risk variants shared between asthma, hay fever, and eczema.

72 D with warts had even higher odds of asthma, hay fever, and food allergies than those with AD and no

73 allergic disease, including asthma, eczema, hay fever, and food allergies.

74 uding asthma, atopic dermatitis (AD)/eczema, hay fever, and food allergies.

75 ciated with concomitant diagnoses of asthma, hay fever, and food allergy and increased disease severi

76 Incorporation of diagnoses of asthma, hay fever, and food allergy improves PPV and specificity

77 in the United States, and history of asthma, hay fever, and food allergy, anemia was associated with

78 n the United States, ever history of asthma, hay fever, and food allergy, eczema was found to be asso

79 sthma, asthma exacerbation in the past year, hay fever, and food allergy.

80 Early IgE sensitization onset, parental hay fever, and higher exposure to mites were associated

81 ons between atopy/allergies, asthma, eczema, hay fever, and hives and childhood/adolescent leukemia,

82 s is observed among people reporting asthma, hay fever, and other allergic conditions; however, findi

83 in the past 12 months and history of asthma, hay fever, and other allergies.

84 ory diseases (asthma, bronchitis, emphysema, hay fever, and pneumonia) in 1,553 lung cancer patients

85 Adults and individuals with asthma, hay fever, and pollen sensitization may be at higher ris

86 were greater in adults with current asthma, hay fever, and pollen sensitization.

87 allergic symptoms in adults (wheeze, asthma, hay fever, and rhinitis).

88 aregiver-reported history of eczema, asthma, hay fever, and/or food allergy.

89 io [aOR], 0.68; 95% CI, 0.59-0.78; P< .001), hay fever (aOR, 0.43; 95% CI, 0.36-0.52; P< .001), atopi

90 ge with histories of diagnosed asthma and/or hay fever are analyzed in the 1995 National Survey of Fa

91 ility rates of women with asthma, eczema, or hay fever are lower than those of women in the general p

92 The diseases of asthma, eczema and hay fever are typified by reactions to common allergens,

93 ed maternal and paternal asthma, eczema, and hay fever as cross-sectional predictors of childhood ast

94 rapy were also demonstrated in patients with hay fever, as an alternative to conventional subcutaneou

95 ng effect modifiers of pollen sensitization, hay fever, asthma, air pollution, green spaces, and pre-

96 f this study was to investigate how parental hay fever, asthma, and eczema affect the risk of allergi

97 usal effect of infantile eczema on childhood hay fever, asthma, or both.

98 of having or having had allergic rhinitis or hay fever at follow-up.

99 or the appearance and subsequent increase in hay fever at that time is the combination of hygiene and

100 effect against atopic manifestations such as hay fever, atopic eczema, allergic sensitization, or ast

101 red to be associated with current asthma and hay fever but not eczema.

102 "Do you have any nasal allergies, including hay fever?" (defining allergic rhinitis) was given by 23

103 es as reported with the aid of the patient's hay-fever diary (PHD).

104 Allergic disorders, such as anaphylaxis, hay fever, eczema and asthma, now afflict roughly 25% of

105 of larger families with lower prevalences of hay fever, eczema and objective markers of allergic sens

106 Risk was inversely associated with asthma, hay fever, eczema, and "any allergy," significantly for

107 hma symptoms and does not reduce the risk of hay fever, eczema, and allergic sensitization.

108 to an increased risk of allergic symptoms of hay fever, eczema, and food allergy later in life.

109 The interviews also inquired about wheeze, hay fever, eczema, and food allergy.

110 easured at 7 years of age (asthma, wheezing, hay fever, eczema, atopy, and total IgE).

111 ars as symptoms, doctor's diagnoses (asthma, hay fever, eczema, food allergy), and measurement of lun

112 and the risk of allergies/atopies including hay fever, eczema, food allergy, positive skin prick tes

113 used data on 5 allergic conditions (allergy, hay fever, eczema, rhinitis, and itchy rash) and serum-s

114 E levels and a strong propensity for asthma; hay fever; eczema; and impaired lung function, also in c

115 for the treatment of seasonal allergies and hay fever, emerges from this methodology.

116 nds (P < 0.0001) were observed for reported 'hay fever ever' and 'eczema ever' with increasing number

117 s controlling for sociodemographics, asthma, hay fever, food allergies, and psychiatric and behaviora

118 zema: one with high probabilities of asthma, hay fever, food allergy, and multiple sleep symptoms and

119 on infantile eczema and childhood asthma and hay fever for 3778 pairs of 7-year-olds matched to their

120 confidence interval (CI): 2.20, 3.76), while hay fever had a significant protective effect (OR = 0.58

121 Women with asthma (with and without hay fever) have significantly higher pregnancy losses th

122 ory of AD (HR, 12.40; 95% CI, 6.97-22.06) or hay fever (HR, 3.78; 95% CI, 1.49-9.53) were associated

123 th eczema in 14 of 17 studies, asthma in 11, hay fever in 12, and food allergy in 12.

124 Before the first description of hay fever in 1870, there was very little awareness of al

125 The US prevalence of hay fever in childhood was 18.0% (95% CI, 17.7% to 18.2%

126 of asthma, wheezing, atopic eczema (AE), and hay fever in children during the first 7 years of life.

127 ema in infancy might have a causal effect on hay fever in children with and perhaps without asthma.

128 mpanied by an increase in atopy, asthma, and hay fever in these villages.

129 Hay fever increased 2-fold in the villages (3.0% vs 7.7%

130 Parental isolated hay fever increased the odds of AR (OR 2.2, 95% CI 1.6-3

131 , both overall and among asthma, eczema, and hay fever investigated separately, and childhood acute l

132 d (2) the link between eczema and asthma and hay fever is independent of shared early-life environmen

133 Allergic rhinitis (AR)-commonly called hay fever-is a widespread condition that affects the qua

134 s reporting both wheeze and doctor-diagnosed hay fever (n = 1,310, 6%) and non-allergic wheeze as rep

135 -allergic wheeze as reporting wheeze but not hay fever (n = 3,939, 18%); men without wheeze were the

136 with atopic symptoms (food allergy, n = 13; hay fever, n = 10; asthma, n = 7).

137 ed about prior doctors' diagnoses of asthma, hay fever/nasal allergies/allergic rhinitis, and eczema.

138 sal microbiome diversity was associated with hay fever, NO(2), and temperature exposure.

139 egative association between NHL and seasonal hay fever (odds ratio (OR) = 0.28, 95% confidence interv

140 t current vs never smokers had lower risk of hay fever (odds ratio (OR) = 0.68, 95% confidence interv

141 (odds ratio = 0.43, 95% CI: 0.21, 0.89) and hay fever (odds ratio = 0.50, 95% CI: 0.25, 1.00) with a

142 Hay fever (odds ratio = 0.74, 95% CI: 0.56, 0.96) and al

143 hma (odds ratio = 0.85, 95% CI: 0.61, 1.18), hay fever (odds ratio = 0.81, 95% CI: 0.62, 1.06), and e

144 For having hay fever only, the association with cosibling's eczema

145 as defined as self-reported doctor diagnosed hay fever or allergic upper respiratory symptoms.

146 rhinitis was defined as physician-diagnosed hay fever or allergy, the presence of symptoms in the pa

147 ma and decreased lung function, but not with hay fever or biomarkers of allergy.

148 e telomere length, allergic disease (asthma, hay fever or eczema), alcohol consumption, childhood obe

149 95% CI of 1.15-2.34 for participants without hay fever or increased IgE levels).

150 oral/pharyngeal symptoms, in the context of hay fever or pollen sensitisation, which can be triggere

151 n, poor mental health, asthma or bronchitis, hay fever or rhinitis, back problems, hearing problems,

152 Migraine, hay fever or rhinitis, eyesight problems, and skin probl

153 ex (OR 2.0 [95% CI, 1.1-3.6]), and childhood hay fever (OR 2.0 [95% CI, 1.0-4.0]) as risk factors for

154 eczema (OR = 0.74, 95% CI: 0.58, 0.96), and hay fever (OR = 0.55, 95% CI: 0.46, 0.66) examined separ

155 rent smokers showed a slightly lower risk of hay fever (OR = 0.958, 95% CI: 0.920, 0.998; P = 0.041),

156 Asthma, hay fever (or allergic rhinitis) and eczema (or atopic d

157 r G allele (OR, 0.98 [95% CI, 0.66-1.47]) or hay fever (OR, 1.11 [95% CI, 0.71-1.72]), nor with any o

158 Sensitization to CG1 was associated with hay fever (OR, 12.79; 95% CI, 6.84-23.90; P < .001).

159 oth asthma (OR, 3.60; 95% CI, 2.05-6.29) and hay fever (OR, 2.52; 95% CI, 1.38-4.61).

160 R=1.009; 95% CI: 1.004, 1.013), but not with hay fever (OR= 0.998; 95% CI: 0.994, 1.002) or allergic

161 ociated with any other allergic disease (for hay fever, OR 0.64, 95% CI 0.53-0.77, P = 2.5*10(-6) ).

162 amined the association between AACs (asthma, hay fever, or allergy) and CRC among white, African-Amer

163 sensitization or prior diagnoses of asthma, hay fever, or eczema in black and white pregnant women.

164 al, but not paternal, atopic status (asthma, hay fever, or eczema with or without sensitization) was

165 eczema) but was not associated with asthma, hay fever, or use of prescription medication.

166 1.97 [1.22-3.16], history of atopic disease (hay fever: OR: 5.50 [3.42-9.00] and atopic dermatitis: O

167 elf-reported doctor's diagnosis of asthma or hay fever; or lung function at 20 years of age.

168 We induced sputum in hay fever patients and healthy controls during the polle

169 AR, 11.0%, in a cluster where one parent had hay fever, pollen allergy, and eczema.

170 ons were modified by current asthma, current hay fever, pollen sensitization, age, and other environm

171 This study addresses whether asthma and/or hay fever predict fertility and impaired fecundity.

172 Hay fever prevalence was significantly lower with second

173 These findings have implications for hay fever prevention.

174 ergens is strongly associated with asthma or hay fever, respectively.

175 phthalate metabolites and allergic symptoms (hay fever, rhinitis, allergy, wheeze, asthma) and sensit

176 Parental hay fever seems to be the dominating hereditary risk fac

177 For hay fever, significantly decreased risks were evident wi

178 For asthma and hay fever, SPT (cutoff value at 3 mm) had a significantl

179 nd wheezing in offspring but not with AE and hay fever, suggesting that pathways may be nonallergic.

180 c sensor data with real-time, geo-positioned hay fever symptom reports to examine the relationship be

181 mary outcome was patient-reported changes in hay fever symptoms assessed by a visual analog scale.

182 Hay fever symptoms during the pollen season were reduced

183 onship exists between urban surroundings and hay fever symptoms.

184 ials found that allergen EPIT can ameliorate hay fever symptoms.

185 The immunotherapy group had reduced hay-fever symptoms, skin-test sensitivity to ragweed, an

186 villages had lower prevalences of asthma and hay fever than children from towns, and in the Phase II

187 SPT has a higher specificity for asthma and hay fever than sIgE without difference for sensitivity.

188 to life-threatening diseases, from seasonal hay fever, through the food allergies, atopic eczema, as

189 We defined current asthma and hay fever using questionnaires and current atopy by bloo

190 year prevalence of eczema with asthma and/or hay fever was 3.2% (95% CI, 2.8% to 3.3%).

191 The American data, however, suggest that hay fever was already common in 1960.

192 2.03; 1.20-3.46; P = .009) while history of hay fever was not associated with anemia (0.85; 0.62-1.1

193 In KORA, hay fever was significantly associated with accelerated

194 ivalent fertility rate ratios for eczema and hay fever were 1.15 (95% CI: 1.13, 1.17) and 1.08 (95% C

195 easing age, female sex, and history of AD or hay fever were associated with higher risk of paradoxica

196 greenness) and respiratory outcomes (asthma, hay fever, wheezing, IgE, aeroallergen sensitization, Fe

197 O(2), temperature) and respiratory outcomes (hay fever, wheezing, IgE, FeNO, lung function) (FDR < 0.

198 fantile eczema on asthma in children without hay fever, which might be early transient wheeze, is unl

199 atopy ranged from 50% for eczema to 72% for hay fever, while the negative predictive value ranged fr

200 P = .04) and eczema (21.9% vs 14.8%) but not hay fever (white women: 17.5% vs black women: 15.7%, P =

201 A matched group of patients with hay fever who had not received immunotherapy was followe

202 iated with asthma, atopic sensitization, and hay fever with odds ratios ranging from 0.17 to 0.73.

203 ty rates among women with asthma, eczema, or hay fever with rates in women without these diagnoses.

204 ty rates among women with asthma, eczema, or hay fever with those in the general female population.